PAM
ATNM icon

Panagora Asset Management’s Actinium Pharmaceuticals ATNM Stock Holding History

Panagora Asset Management’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,753
Closed -$13K – 2472
2019
Q2 		$13K Sell
1,753
-195
-10% -$1.96K ﹤0.01% 2357
2019
Q1 		$28K Sell
1,948
-1,812
-48% -$28.9K ﹤0.01% 2185
2018
Q4 		$44K Sell
3,760
-71
-2% -$1.21K ﹤0.01% 1991
2018
Q3 		$85K Buy
3,831
+358
+10% +$7.29K ﹤0.01% 1904
2018
Q2 		$67K Hold
3,473
– – ﹤0.01% 1976
2018
Q1 		$38K Buy
+3,473
New +$59K ﹤0.01% 2103

Other funds holding ATNM

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Panagora Asset Management's ATNM Position: Q3 2019 in Review

Panagora Asset Management sold out of Actinium Pharmaceuticals (ATNM) in Q3 2019, closing a stake of 1,753 shares — an estimated $13K sold.

Panagora Asset Management first reported a position in ATNM in Q1 2018 and held it in 6 quarters. The position peaked at $85K in Q3 2018. 40 funds tracked by Wall St. Rank hold ATNM as of Q3 2019.

  • Panagora Asset Management reported no remaining Actinium Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Panagora Asset Management sold 1,753 Actinium Pharmaceuticals shares in Q3 2019, an estimated $13K.
  • Panagora Asset Management first reported a position in Actinium Pharmaceuticals in Q1 2018 and held it in 6 quarters.
  • Panagora Asset Management's Actinium Pharmaceuticals position peaked at $85K in Q3 2018.
  • 40 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.